Although there is a wealth of research regarding the role of TGF-β signaling in the pathogenesis of PDA, to our knowledge there are no other studies evaluating the direct role of TGF-β blockade as a treatment for cachexia in this disease. Here, TGFB1 is linked to Patent ductus arteriosus.